The review identifies that for many cancer patients and those with rare diseases, financial burdens can be as devastating as the disease itself. The staggering costs associated with treatment, combined with the uncertainty surrounding insurance and healthcare coverage, can lead families to financial ruin. It highlights the distressing reality that many patients often choose between life-saving treatments and their financial stability. By examining these issues, the researchers aim to raise awareness and foster discussion around the urgent need for effective financial protection strategies.

One pivotal focus of the review is the various barriers that hinder access to affordable healthcare. These barriers include high out-of-pocket expenses, insufficient insurance coverage, and a lack of clear information about available financial assistance programs. The researchers fronted that without adequate support systems in place, patients may forgo necessary treatments, ultimately exacerbating health disparities and leading to worse clinical outcomes. This situation is intolerable, and the review positions itself as a call to action for policymakers, healthcare providers, and stakeholders.

As the review unfolds, it categorizes existing financial protection strategies into various models, analyzing their potential effectiveness within different healthcare systems. For example, universal health coverage models demonstrate promise in minimizing out-of-pocket costs, provided that they are implemented effectively. These strategies, if tailored correctly to meet the needs of patients with cancer and special diseases, could greatly enhance their financial stability and quality of care.

Another cornerstone of the review revolves around patient education and informed decision-making. Researchers emphasize that empowering patients with knowledge about available financial resources can alleviate some of the stress associated with financial burdens. Programs designed to increase literacy around healthcare financing are crucial in enabling patients to navigate their options confidently. They encourage healthcare providers to engage in conversations with patients about financial assistance, ensuring that no one is left in the dark amidst their healthcare journey.

Innovative approaches such as risk-sharing arrangements are also explored in the review. These arrangements can potentially reshape the landscape of healthcare financing by sharing the financial burden between healthcare payers and patients. By structuring payments based on treatment outcomes, these models incentivize providers to deliver high-quality, effective care. This not only benefits patients but also fosters a culture of accountability within healthcare systems.

Moreover, the scoping review shines a spotlight on governmental and non-governmental interventions that aim to support patients from a financial standpoint. Subsidies, grants, and healthcare vouchers aimed specifically at cancer and rare disease patients can be instrumental in bridging the financial gap faced by many families. The researchers argue that such initiatives need to be carefully designed and adequately funded to be truly beneficial.

The impact of socioeconomic factors on healthcare access is another critical theme the researchers address. Various studies suggest that low-income patients often delay treatment due to financial anxiety. The review makes a compelling case for tailored strategies that address these disparities by considering the unique challenges faced by different demographic groups. Understanding these hurdles can pave the way for more equitable healthcare practices and policies.

As the discussion progresses, the review showcases examples of successful financial protection strategies implemented across various countries. Comparative analyses demonstrate that successful models often share common characteristics, including robust government support, comprehensive coverage, and a focus on patient engagement. By learning from these examples, other healthcare systems can develop and refine their approaches to financial protection for vulnerable populations.

The importance of collaboration between various stakeholders is another key takeaway from the review. Partnerships between governmental agencies, healthcare providers, pharmaceutical companies, and patient advocacy groups can yield innovative solutions to financial barriers. Collaborative efforts can drive resource allocation towards initiatives that aim to shield patients from oppressive financial pressures associated with treatment.

Additionally, the role of technology in enhancing financial protection is highlighted throughout the review. Digital health tools, including telemedicine and mobile applications, have the potential to increase access to healthcare and financial resources. These tools can help patients better track their expenses, making informed choices more accessible and encouraging proactive management of their health finances.

In conclusion, the scoping review authored by Makhtoomi and colleagues serves as a vital contribution to the discourse on financial protection strategies for cancer and special disease patients. By illuminating existing strategies and advocating for innovative approaches, the researchers aim to stimulate action towards a more equitable healthcare system. As the world continues to grapple with the financial implications of healthcare, this review serves as a reminder of the necessity for systemic change to ensure that the burden of disease does not escalate into a burden of financial despair.

The intricate relationship between health and finance cannot be overlooked. With increasing patient populations facing significant healthcare costs, the call for comprehensive reform is not just timely but essential. Bolstering financial protection for vulnerable patients is a moral imperative that transcends borders and demands an urgent unified response from every healthcare stakeholder.

Ultimately, it is clear that innovative financial protection strategies are not merely options; they are essential pathways to enhancing patient well-being, health equity, and the overall effectiveness of healthcare systems worldwide. The journey towards achieving this goal necessitates collaboration, commitment, and creativity among all participants within the healthcare ecosystem.

Subject of Research: Financial Protection Strategies for Patients with Cancer or Special Diseases

Article Title: Strategies for financial protection for patients with cancer or special diseases in the health system: A scoping review

Article References:

Makhtoomi, V., Raeisi, P., Rezapour, A. et al. Strategies for financial protection for patients with cancer or special diseases in the health system: A scoping review.
Health Res Policy Sys 23, 121 (2025). https://doi.org/10.1186/s12961-025-01372-2

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12961-025-01372-2

Keywords: financial protection, cancer patients, healthcare costs, health equity, innovative strategies, universal health coverage, patient education, healthcare financing, risk-sharing arrangements, collaborative efforts, outcomes-based payments.

The core argument of this research revolves around a simple yet profound insight: physical distance alone is insufficient to capture the true barriers patients face when seeking primary healthcare. While geography indisputably influences access, the economic costs—both direct and indirect—that patients incur are equally significant. Out-of-pocket expenses, lost wages due to travel and waiting times, and ancillary costs such as transportation fares cumulatively shape a patient’s ability to access care. The research team led by Zhu, Chen, and He advocates for an integrated model that simultaneously accounts for spatial and economic dimensions to provide a holistic accessibility analysis.

Methodologically, the study leverages advanced geospatial datasets combined with economic indicators sourced from diverse populations. Utilizing population density maps, healthcare facility locations, and detailed cost surveys, the researchers develop an innovative computational framework. This model quantifies healthcare accessibility by simultaneously evaluating travel distance and the economic burden imposed on individuals. Intriguingly, the model adjusts accessibility indices by weighting economic factors, rendering a nuanced portrait of healthcare landscapes that traditional distance-based metrics fail to capture.

One of the study’s impressive innovations lies in the scale and granularity of the analysis. Applying their integrated framework at a large scale, the authors examine vast geographic regions with heterogeneous socio-economic and demographic characteristics. This level of expansive yet detailed analysis establishes critical insights into how economic disparities intersect with spatial constraints, revealing unequal healthcare access patterns invisible through a singular spatial lens. The combinatorial approach enables the identification of populations most vulnerable to healthcare inaccessibility, guiding targeted interventions.

The implications of this research ripple powerfully across multiple domains. For policymakers, the integrated model offers a robust decision-support tool to prioritize investments that alleviate both physical and economic barriers. Healthcare infrastructure planning can now incorporate economic burden metrics, ensuring that expansions or improvements in service locations align effectively with community affordability. Furthermore, insurance frameworks and subsidy programs can be better tailored to mitigate financial barriers, ultimately fostering more equitable health outcomes.

Economically, the model underscores how financial hardship extends beyond mere expenses for treatment. Indirect costs, such as lost income due to time spent seeking care and the costs linked to transportation or childcare, accumulate substantially in disadvantaged populations. The model’s capacity to quantify these elements underscores an urgent need for policy frameworks that consider totality of economic burdens rather than isolated costs. This could catalyze reforms in social welfare programs and strengthen safety nets surrounding health expenditures.

Technically, the application of geographic information systems (GIS) integrated with economic data represents a remarkable innovation in health systems research. By coupling spatial analytics with microeconomic modeling, the research pushes the frontier of accessibility analyses. The use of multi-dimensional datasets demands sophisticated computational tools and algorithms, which the researchers adeptly implement. Such cross-disciplinary integration showcases the potential of technology-driven approaches to unravel complex social problems like healthcare access.

The study also contributes to advancing equity frameworks in global health. Health equity advocates have long called for a multidimensional approach toward understanding barriers to care. This research answers that call by supplying empirical evidence and refined methodologies to operationalize equity considerations. By directly linking economic parameters to accessibility metrics, the researchers bridge theory and practice, providing a foundation for equitable health system design and evaluation.

Beyond academia and policy, the human impact of integrating economic burden into accessibility assessments is profound. Individuals and families navigating healthcare decisions often face hidden costs that discourage timely care-seeking, worsening health outcomes. This model surfaces these often-unseen barriers, generating awareness among stakeholders from governments to community organizations. Highlighting the compounded disadvantages some populations endure can galvanize multisectoral collaborations aimed at systemic change.

The applicability of the integrated accessibility model extends globally. While the study focuses on specific regions as case studies, the modeling framework is adaptable to various countries and healthcare contexts. This scalability positions the research as a blueprint for international health agencies and local governments aspiring to improve primary healthcare access in diverse settings. It facilitates cross-country comparisons and the sharing of best practices informed by comprehensive, data-driven analysis.

The research also opens avenues for future explorations. One promising direction is the integration of real-time data streams, such as mobile health tracking or economic transaction records, to dynamically update accessibility assessments. Coupling behavioral insights with economic and spatial data could further refine understanding of patient decision-making processes. Moreover, embedding quality and service capacity metrics alongside economic considerations could produce even richer, multi-layered models of healthcare access.

Importantly, the study challenges established health access paradigms by questioning assumptions that equate proximity with adequate access. This paradigm shift encourages re-evaluations of how healthcare systems identify underserved areas. Recognizing that a health facility within close physical range may still be economically inaccessible demands recalibrated evaluation frameworks. The research thus invites a more empathetic and comprehensive perspective on health equity, highlighting the lived realities of marginalized populations.

In the broader context of health systems strengthening, the study’s integrated approach contributes to the ongoing global discourse on universal health coverage (UHC). Achieving UHC hinges not only on service availability but also on removing financial barriers to care. Thus, incorporating economic burden into accessibility models aligns directly with UHC objectives. The findings could influence global health strategies, ensuring resource allocations are guided by a more inclusive understanding of access.

From a technical standpoint, the researchers have adeptly navigated challenges related to data heterogeneity and model validation. Combining economic surveys, demographic records, and geospatial layers requires rigorous alignment procedures and sensitivity analyses. The robustness of the model is strengthened by methodological transparency and validation against ground-truth accessibility indicators. This methodological rigor enhances confidence in the model’s real-world applicability and potential for policy impact.

Another aspect of the study worth noting is its interdisciplinary essence. The research team integrates expertise from public health, economics, geography, computer science, and social policy. This collaborative approach exemplifies how complex societal challenges—like healthcare accessibility—require convergence of diverse perspectives and tools. The resulting model reflects this synergy by marrying technical innovation with social empathy.

In conclusion, this pioneering research marks a significant leap in the science of healthcare accessibility. By moving beyond the simplistic measure of distance to embrace the nuanced realities of economic burden, the study equips stakeholders with a powerful instrument to identify, understand, and rectify healthcare access inequities on a grand scale. As global health systems grapple with the challenges of equity and sustainability, such integrative models will undoubtedly become critical pillars supporting transformative change.

Subject of Research: Integrating economic burden into large-scale primary healthcare accessibility analysis

Article Title: Beyond distance: integrating economic burden into large-scale primary healthcare accessibility analysis

Article References:

Zhu, B., Chen, L., He, Y. et al. Beyond distance: integrating economic burden into large-scale primary healthcare accessibility analysis. glob health res policy 10, 53 (2025). https://doi.org/10.1186/s41256-025-00451-9

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s41256-025-00451-9

India’s healthcare ecosystem, emblematic of many low- and middle-income countries, bears the brunt of systemic inadequacies. Despite progress in expanding healthcare access, a substantial proportion of expenditures remains out-of-pocket, disproportionately burdening the poor. The study meticulously captures the nuances behind these out-of-pocket costs and their implications, highlighting that illness is not merely a health concern but a socio-economic crisis. These findings underscore how the intersection of inadequate medical coverage and socio-economic vulnerability leads to a multitude of adverse coping mechanisms that have severe consequences on household stability and well-being.

By conducting extensive qualitative interviews with affected households, the researchers provide a rich narrative that transcends numerical data, illuminating how individuals and families strategize to manage crippling health costs. The emergence of hardship financing – including borrowing from informal lenders, selling assets, and even child labor – emerges as a distressing yet pervasive phenomenon. Importantly, the authors dissect the long-term ramifications of such practices, detailing how these coping mechanisms often dismantle social safety nets, erode savings, and jeopardize future income-generating potential, thereby entrenching families in deeper economic peril.

The study further illustrates the nuanced dynamics between the type of illness and the resultant financial hardship, demonstrating that chronic conditions and sudden health shocks both have unique socio-economic footprints. Chronic illnesses tend to impose ongoing financial strain, often silently draining resources over time, while acute or catastrophic events provoke immediate and severe economic fallout. This differentiation is critical to policies aimed at mitigating healthcare-induced poverty, suggesting that interventions require tailored approaches that address both immediate and enduring financial risks.

Health insurance coverage in India, while expanding, is frequently inadequate or inaccessible to marginalized populations, a gap the researchers identify as a key factor in amplifying hardship financing. Many participants highlighted challenges in navigating insurance schemes or expressed skepticism regarding their efficacy, reflecting a broader systemic failure. The study’s in-depth exploration of insurance-related barriers points to a pressing need for policy reforms that ensure not only coverage expansion but also equitable access, comprehensiveness, and reliability, especially for the most vulnerable segments of society.

In the backdrop of these challenges, informal credit markets play an outsized role in enabling healthcare financing for the poor. Borrowing from moneylenders or community members is a double-edged sword: while providing immediate relief, it often traps borrowers in cycles of indebtedness due to exorbitant interest rates and stringent repayment expectations. The qualitative data richly captures these socio-economic entrapments, revealing how such debts can spiral, forcing households to make agonizing choices between health and sustenance, effectively compromising both.

In addition to borrowing, asset sales emerged as a common coping mechanism, with many families liquidating productive assets like livestock or agricultural tools. This strategy temporarily alleviates financial pressure but undermines long-term income generation, particularly in rural settings where livelihoods depend heavily on physical assets. The researchers highlight this pattern as a pernicious factor in sustained poverty, calling for policy interventions aimed at cushioning households from the need to deplete their asset base during health crises.

Another poignant revelation from the study is the intersection of healthcare hardship financing with social inequities related to caste, gender, and rural-urban divides. Marginalized groups, including Scheduled Castes and tribal communities, tend to experience disproportionate financial strain due to systemic exclusion from formal financial and health services. Women, often primary caregivers, face additional burdens, frequently sacrificing their own health needs to prioritize others. The research provides urgent evidence that addressing healthcare-induced poverty requires intersectional policies that tackle these deeply ingrained social disparities.

Mental health consequences of hardship financing also emerge as a significant concern within the study’s findings. The financial stress associated with healthcare costs is linked to increased anxiety, depression, and social stigma. Households reported feeling isolated or ashamed due to their inability to meet health expenses without resorting to extreme measures. These psychosocial impacts underscore the importance of integrating mental health support within broader healthcare and social protection frameworks to holistically combat the toll of illness-related poverty.

From a health systems perspective, the study critically examines the role of government facilities and public health expenditures, revealing significant gaps in service availability and quality. Participants recounted experiences of inadequate infrastructure, insufficient drug supply, and informal payments even within supposed free public care settings. Such systemic deficiencies compel patients to seek private care, often at higher costs, thereby intensifying financial burdens. The research calls for strengthened public health investments coupled with accountability mechanisms to rebuild trust and reduce financial reliance on private sector services.

Policy implications from this study are manifold and urgent. The researchers advocate for innovative social protection measures such as conditional cash transfers, interest-free loan schemes, and strengthened community health insurance models tailored to the poor’s realities. They emphasize the importance of transparency and community engagement in healthcare finance policies to ensure responsiveness and fairness. Furthermore, strategic investments in primary healthcare strengthening, coupled with better regulation of the informal credit market, are proposed as critical pathways to mitigate the multifaceted dimensions of hardship financing.

The study’s qualitative approach, embracing narratives from diverse geographic regions and socio-economic backgrounds across India, lends robustness and depth to its conclusions. Unlike purely quantitative surveys, this method reveals the lived experiences behind cold statistics, giving voice to those often marginalized in policy discourse. By illuminating the human stories intertwined with illness-induced poverty, Thomas, Sahu, and Dash’s work provides a compelling argument for reframing healthcare access as a fundamental equity issue rather than a mere service provision challenge.

Looking ahead, the implications of this research extend beyond India, offering significant lessons for other low- and middle-income countries grappling with similar healthcare financing dilemmas. The study’s insights into the mechanisms of hardship financing and their socio-economic fallout provide a crucial empirical foundation for global health equity advocates working to design inclusive financial protection policies. International development programs and health financing reforms would benefit from incorporating such qualitative evidence to craft nuanced, culturally sensitive interventions.

This study also invites renewed academic debate on the relationship between health shocks and poverty traps, challenging simplistic causal models. The authors underscore the need for more interdisciplinary research that bridges economic theory, public health, and social science to uncover the complexity of household decision-making in resource-constrained environments. Such integrated approaches are essential to develop comprehensive policies that address both the economic and social dimensions of health vulnerability.

In conclusion, the illuminating research by Thomas, Sahu, and Dash represents a landmark contribution to contemporary health equity scholarship. Their work meticulously charts the perilous journey from illness to poverty in India, exposing the profound vulnerabilities embedded in current healthcare financing systems. As nations worldwide strive to achieve universal health coverage and financial protection, insights from this qualitative study serve as a beacon, reminding policymakers and practitioners that true equity entails safeguarding the marginalized from the devastating economic consequences of illness.

Subject of Research: Hardship financing for healthcare and its impact on poverty in India.

Article Title: Illness to poverty in India: a qualitative exploration of hardship financing for healthcare.

Article References:
Thomas, A., Sahu, S. & Dash, U. Illness to poverty in India: a qualitative exploration of hardship financing for healthcare. Int J Equity Health 24, 307 (2025). https://doi.org/10.1186/s12939-025-02666-1

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12939-025-02666-1

Leukemia, a malignant hematological cancer prevalent among children, necessitates intensive, sustained medical intervention, including chemotherapy, hospitalization, and supportive care. The financial weight of such treatment regimens in China, where out-of-pocket healthcare spending remains substantial despite public insurance schemes, presents a profound obstacle for affected families. The study by Su, Zhang, Shao, and colleagues addresses the central question: Can charitable medical assistance programs meaningfully reduce the incidence of catastrophic health expenditures (CHE) in these high-need patient populations? Through rigorous statistical methodologies and an evidence-based framework, the authors dissect the socioeconomic variables intertwined with healthcare financing outcomes.

Critically, the research delineates ‘catastrophic medical expenditures’ as healthcare costs exceeding a significant threshold of a household’s income, defining it as a primary driver of financial impoverishment. The authors harness nationwide survey data, enriched by longitudinal elements, to isolate the effect of charitable assistance amidst a complex matrix of insurance coverage types, income strata, urban versus rural residency, and treatment modalities. This comprehensive analytic approach ensures robustness, minimizing confounding factors that commonly obscure causal inferences in health economics research.

The authors uncover that families of children with leukemia who engaged with charitable medical assistance programs were demonstrably less likely to incur catastrophic expenditure levels compared to counterparts lacking such support. This protective effect remained statistically significant even after adjusting for income variations and baseline insurance coverage. The findings suggest that these charitable programs effectively fill critical gaps left by existing healthcare financing mechanisms, particularly for families below certain socioeconomic thresholds. Moreover, the study provides nuanced insights into the differential impact of assistance depending on geographic location and treatment intensity.

Behind the data lies a complex interplay of healthcare policy, social welfare structures, and the sociocultural dimensions of aid acceptance. The study highlights that while China has made impressive strides expanding basic medical insurance penetration, out-of-pocket expenditures for chronic and severe diseases remain disproportionately high. Charitable assistance programs, which often encompass both direct financial support and supplementary services like counseling and logistics assistance, enhance access and adherence to prescribed treatment regimens. This multi-faceted support paradigm emerges as vital in not only reducing financial toxicity but also in improving clinical outcomes indirectly through sustained treatment engagement.

Technically, the evaluation methods utilized by the researchers involved advanced econometric models, including propensity score matching and hierarchical regression analyses, to ensure that observed differences in expenditure outcomes are attributable to the intervention rather than selection biases. This methodological rigor elevates the study’s credibility, making its policy implications highly persuasive for stakeholders. The researchers also stress the importance of further continuing surveillance and adaptive design improvements in charitable assistance programs to maximize their efficiency and equity impact.

One particularly salient aspect of the findings relates to the heterogeneity of program effects across different demographic segments. Urban families, with comparatively higher baseline incomes and better insurance, still benefited from assistance, but the magnitude of reduction in catastrophic expenses was more pronounced in rural or lower-income families. This underscores the continued urban-rural divide in healthcare access and financing resilience within China, a reality echoed in many emerging economies. Tailoring assistance frameworks to these disparities could further optimize the programs’ equity-enhancing outcomes.

The implications extend beyond national boundaries, presenting an evidence-informed template for other low- and middle-income countries confronting similar epidemiological and healthcare financing challenges. The study’s emphasis on transparent evaluation metrics and outcome tracking sets a precedent for global health initiatives targeting financial risk protection in pediatric oncology and chronic disease management. Importantly, by framing charitable medical assistance not as mere philanthropy but as an integral component in healthcare system strengthening, the findings promote a reconceptualization of public-private partnerships in health.

Furthermore, this investigation surfaces a broader discourse on the sustainability and scalability of charitable assistance in health systems undergoing reform. While such programs have immediate positive impacts, reliance on philanthropic sources can be inherently unstable. The authors advocate for strategic integration of charitable assistance into formal health financing schemes, ensuring alignment with national health priorities and regulatory oversight. This integration could manifest as co-financing mechanisms, incentivizing philanthropic engagement while anchoring patient support within systemic frameworks.

Interestingly, the study also explored the psycho-social dimensions implicit in charitable medical assistance. Qualitative data revealed that families receiving assistance experienced reduced anxiety and better psychological resilience throughout their child’s treatment journey. These aspects, though challenging to quantify, are crucial mediators of overall health outcomes and affirm the holistic benefits of such programs beyond sheer financial metrics. This humanistic perspective aligns with emerging global health paradigms emphasizing patient-centered care and comprehensive support systems.

From a technological standpoint, the researchers also observed the growing role of digital health tools and data analytics in optimizing charitable resource allocation and patient tracking. Leveraging electronic health records and mobile health platforms, program administrators can identify eligible patients more efficiently and monitor expenditure patterns in near real-time. Such innovations pave the way for dynamic, responsive assistance mechanisms that continually adapt to evolving patient needs and economic fluctuations, thereby enhancing program effectiveness and accountability.

The research further contextualizes its findings within broader epidemiological trends, noting the rising incidence of pediatric cancers worldwide and the consequent amplification of associated economic burdens. As survival rates improve due to medical advancements, the long-term financial sustainability of treatment becomes paramount. Charitable assistance thus performs a dual function—mitigating immediate fiscal distress and supporting long-term treatment adherence, both crucial for favorable clinical trajectories in childhood leukemia.

Critics might caution against over-reliance on charitable programs, pointing to disparities in geographic availability and possible stigmatization attached to aid receipt. The authors acknowledge these concerns and recommend policy frameworks that prioritize equitable access and destigmatization campaigns, fostering inclusive support environments. Tailored communication strategies, community engagement, and transparency in resource distribution emerge as essential components for program acceptance and success.

In conclusion, the comprehensive evidence provided by Su and colleagues delineates a clear, quantifiable benefit of charitable medical assistance programs in reducing catastrophic medical expenditures for families with children battling leukemia in China. This landmark study not only enriches the understanding of healthcare financing dynamics in vulnerable populations but also serves as a call to action for integrating charitable assistance into broader health equity strategies. With meticulous methodological design and insightful policy analysis, it charts a viable pathway toward alleviating the economic devastation wrought by severe pediatric illnesses.

These findings resonate far beyond the confines of pediatric oncology, offering a replicable framework for addressing catastrophic health spending across diverse disease landscapes and demographic contexts. As global health actors strive toward universal health coverage and financial risk protection, empirical studies like this one form the cornerstone of evidence-based policy formulation. The convergence of rigorous research, innovative financing models, and compassionate care delivery heralds a transformative era in mitigating the collateral damage of serious illness on families worldwide.

Subject of Research: Impact of charitable medical assistance programs on catastrophic medical expenditures for families with children diagnosed with leukemia in China

Article Title: Does the charitable medical assistance program impact catastrophic medical expenditures for families of children with leukemia? An evidence-based study in China

Article References:
Su, J., Zhang, Yq., Shao, D. et al. Does the charitable medical assistance program impact catastrophic medical expenditures for families of children with leukemia? An evidence-based study in China. Int J Equity Health 24, 75 (2025). https://doi.org/10.1186/s12939-025-02442-1

Image Credits: AI Generated